Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III MelanomaRobyn D Gartrell, Douglas K Marks, Emanuelle M Rizk, et al.
Oncotarget|August 7, 2019
Oncologist uptake of comprehensive genomic profile guided targeted therapyMary K Nesline, Paul DePietro, Grace K Dy, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinomaLandon C Brown, Jason Zhu, Kunal Desai, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Nature Communications|July 17, 2025
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBCQian Zhu, Akhila Balasubramanian, Jaya Ruth Asirvatham, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBCQian Zhu, Akhila Balasubramanian, Jaya Ruth Asirvatham, et al.
Carcinogenesis|April 19, 2012
Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencingPengyuan Liu, Carl Morrison, Liang Wang, et al.
Oncoimmunology|September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patientsTian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Journal for Immunotherapy of Cancer|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burdenCarl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
AADAT-Driven Metabolic Control of Malate and CoQ <sub>10</sub> Shapes Immune Evasion in Triple-Negative Breast CancerMegha Chatterjee, Franklin Gu, Susmita Samanta, et al.
Pageof 12